Form 8-K - Current report:
SEC Accession No. 0001140361-24-045431
Filing Date
2024-11-06
Accepted
2024-11-06 17:02:18
Documents
18
Period of Report
2024-10-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20038185_8k.htm   iXBRL 8-K 38969
2 EXHIBIT 99.1 ef20038185_ex99-1.htm EX-99.1 103920
6 image1.jpg GRAPHIC 27499
7 image2.jpg GRAPHIC 159813
8 image3.jpg GRAPHIC 159671
9 image4.jpg GRAPHIC 10390
  Complete submission text file 0001140361-24-045431.txt   794887

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlry-20241031.xsd EX-101.SCH 3976
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20241031_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20241031_pre.xml EX-101.PRE 16040
20 EXTRACTED XBRL INSTANCE DOCUMENT ef20038185_8k_htm.xml XML 4216
Mailing Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065
Business Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065 519.322.8800
Tilray Brands, Inc. (Filer) CIK: 0001731348 (see all company filings)

EIN.: 824310622 | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 001-38594 | Film No.: 241432032
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)